Selected research
Market Analysis & Forecast
Global Brain Disease Device and Software Market Analysis and Forecast 2026-2032
Market perspective
The global Brain Disease Device and Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Brain Disease Device and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Brain Disease Device and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Brain Disease Device and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Brain Disease Device and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Brain Disease Device and Software include United Imaging Healthcare Co., Ltd, Koninklijke Philips N.V., GE, Canon, Inc, Siemens Healthineers AG, Vuno Co., Ltd, Fujifilm Holdings Corporation, Aspect Imaging and IXICO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Brain Disease Device and Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Brain Disease Device and Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Brain Disease Device and Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Brain Disease Device and Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Brain Disease Device and Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Brain Disease Device and Software revenue, projected growth trends, production technology, application and end-user industry.
Brain Disease Device and Software Segment by Company
United Imaging Healthcare Co., Ltd
Koninklijke Philips N.V.
GE
Canon, Inc
Siemens Healthineers AG
Vuno Co., Ltd
Fujifilm Holdings Corporation
Aspect Imaging
IXICO
QMENTA
Cortechs.ai
Quantib
Brainomix
Qure.AI
Imaging Biometrics, LLC
A.I. Analysis, Inc
Brain Disease Device and Software Segment by Type
Brain Disease Device
Brain Disease Software
Brain Disease Device and Software Segment by Application
Hospitals and Clinics
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Brain Disease Device and Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Disease Device and Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brain Disease Device and Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Disease Device and Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Brain Disease Device and Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Brain Disease Device and Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain Disease Device and Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain Disease Device
- Brain Disease Software
Applications
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
Companies covered
- United Imaging Healthcare Co., Ltd
- Koninklijke Philips N.V.
- GE
- Canon, Inc
- Siemens Healthineers AG
- Vuno Co., Ltd
- Fujifilm Holdings Corporation
- Aspect Imaging
- IXICO
- QMENTA
- Cortechs.ai
- Quantib
- Brainomix
- Qure.AI
- Imaging Biometrics, LLC
- A.I. Analysis, Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Brain Disease Device and Software Market by Type
- 1.2.1 Global Brain Disease Device and Software Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Brain Disease Device
- 1.2.3 Brain Disease Software
- 1.3 Brain Disease Device and Software Market by Application
- 1.3.1 Global Brain Disease Device and Software Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals and Clinics
- 1.3.3 Diagnostic Imaging Centers
- 1.3.4 Ambulatory Surgical Centers
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Brain Disease Device and Software Market Dynamics
- 2.1 Brain Disease Device and Software Industry Trends
- 2.2 Brain Disease Device and Software Industry Drivers
- 2.3 Brain Disease Device and Software Industry Opportunities and Challenges
- 2.4 Brain Disease Device and Software Industry Restraints
3 Global Growth Perspective
- 3.1 Global Brain Disease Device and Software Market Perspective (2021-2032)
- 3.2 Global Brain Disease Device and Software Growth Trends by Region
- 3.2.1 Global Brain Disease Device and Software Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Brain Disease Device and Software Market Size by Region (2021-2026)
- 3.2.3 Global Brain Disease Device and Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Brain Disease Device and Software Revenue by Players
- 4.1.1 Global Brain Disease Device and Software Revenue by Players (2021-2026)
- 4.1.2 Global Brain Disease Device and Software Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Brain Disease Device and Software Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Brain Disease Device and Software Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Brain Disease Device and Software Key Players Headquarters & Area Served
- 4.4 Global Brain Disease Device and Software Players, Product Type & Application
- 4.5 Global Brain Disease Device and Software Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Brain Disease Device and Software Market CR5 and HHI
- 4.6.3 2025 Brain Disease Device and Software Tier 1, Tier 2, and Tier 3
5 Brain Disease Device and Software Market Size by Type
- 5.1 Global Brain Disease Device and Software Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Brain Disease Device and Software Revenue by Type (2021-2032)
- 5.3 Global Brain Disease Device and Software Revenue Market Share by Type (2021-2032)
6 Brain Disease Device and Software Market Size by Application
- 6.1 Global Brain Disease Device and Software Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Brain Disease Device and Software Revenue by Application (2021-2032)
- 6.3 Global Brain Disease Device and Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 United Imaging Healthcare Co., Ltd
- 7.1.1 United Imaging Healthcare Co., Ltd Company Information
- 7.1.2 United Imaging Healthcare Co., Ltd Business Overview
- 7.1.3 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.1.4 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Product Portfolio
- 7.1.5 United Imaging Healthcare Co., Ltd Recent Developments
- 7.2 Koninklijke Philips N.V.
- 7.2.1 Koninklijke Philips N.V. Company Information
- 7.2.2 Koninklijke Philips N.V. Business Overview
- 7.2.3 Koninklijke Philips N.V. Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.2.4 Koninklijke Philips N.V. Brain Disease Device and Software Product Portfolio
- 7.2.5 Koninklijke Philips N.V. Recent Developments
- 7.3 GE
- 7.3.1 GE Company Information
- 7.3.2 GE Business Overview
- 7.3.3 GE Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.3.4 GE Brain Disease Device and Software Product Portfolio
- 7.3.5 GE Recent Developments
- 7.4 Canon, Inc
- 7.4.1 Canon, Inc Company Information
- 7.4.2 Canon, Inc Business Overview
- 7.4.3 Canon, Inc Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.4.4 Canon, Inc Brain Disease Device and Software Product Portfolio
- 7.4.5 Canon, Inc Recent Developments
- 7.5 Siemens Healthineers AG
- 7.5.1 Siemens Healthineers AG Company Information
- 7.5.2 Siemens Healthineers AG Business Overview
- 7.5.3 Siemens Healthineers AG Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.5.4 Siemens Healthineers AG Brain Disease Device and Software Product Portfolio
- 7.5.5 Siemens Healthineers AG Recent Developments
- 7.6 Vuno Co., Ltd
- 7.6.1 Vuno Co., Ltd Company Information
- 7.6.2 Vuno Co., Ltd Business Overview
- 7.6.3 Vuno Co., Ltd Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.6.4 Vuno Co., Ltd Brain Disease Device and Software Product Portfolio
- 7.6.5 Vuno Co., Ltd Recent Developments
- 7.7 Fujifilm Holdings Corporation
- 7.7.1 Fujifilm Holdings Corporation Company Information
- 7.7.2 Fujifilm Holdings Corporation Business Overview
- 7.7.3 Fujifilm Holdings Corporation Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.7.4 Fujifilm Holdings Corporation Brain Disease Device and Software Product Portfolio
- 7.7.5 Fujifilm Holdings Corporation Recent Developments
- 7.8 Aspect Imaging
- 7.8.1 Aspect Imaging Company Information
- 7.8.2 Aspect Imaging Business Overview
- 7.8.3 Aspect Imaging Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.8.4 Aspect Imaging Brain Disease Device and Software Product Portfolio
- 7.8.5 Aspect Imaging Recent Developments
- 7.9 IXICO
- 7.9.1 IXICO Company Information
- 7.9.2 IXICO Business Overview
- 7.9.3 IXICO Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.9.4 IXICO Brain Disease Device and Software Product Portfolio
- 7.9.5 IXICO Recent Developments
- 7.10 QMENTA
- 7.10.1 QMENTA Company Information
- 7.10.2 QMENTA Business Overview
- 7.10.3 QMENTA Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.10.4 QMENTA Brain Disease Device and Software Product Portfolio
- 7.10.5 QMENTA Recent Developments
- 7.11 Cortechs.ai
- 7.11.1 Cortechs.ai Company Information
- 7.11.2 Cortechs.ai Business Overview
- 7.11.3 Cortechs.ai Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.11.4 Cortechs.ai Brain Disease Device and Software Product Portfolio
- 7.11.5 Cortechs.ai Recent Developments
- 7.12 Quantib
- 7.12.1 Quantib Company Information
- 7.12.2 Quantib Business Overview
- 7.12.3 Quantib Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.12.4 Quantib Brain Disease Device and Software Product Portfolio
- 7.12.5 Quantib Recent Developments
- 7.13 Brainomix
- 7.13.1 Brainomix Company Information
- 7.13.2 Brainomix Business Overview
- 7.13.3 Brainomix Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.13.4 Brainomix Brain Disease Device and Software Product Portfolio
- 7.13.5 Brainomix Recent Developments
- 7.14 Qure.AI
- 7.14.1 Qure.AI Company Information
- 7.14.2 Qure.AI Business Overview
- 7.14.3 Qure.AI Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.14.4 Qure.AI Brain Disease Device and Software Product Portfolio
- 7.14.5 Qure.AI Recent Developments
- 7.15 Imaging Biometrics, LLC
- 7.15.1 Imaging Biometrics, LLC Company Information
- 7.15.2 Imaging Biometrics, LLC Business Overview
- 7.15.3 Imaging Biometrics, LLC Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.15.4 Imaging Biometrics, LLC Brain Disease Device and Software Product Portfolio
- 7.15.5 Imaging Biometrics, LLC Recent Developments
- 7.16 A.I. Analysis, Inc
- 7.16.1 A.I. Analysis, Inc Company Information
- 7.16.2 A.I. Analysis, Inc Business Overview
- 7.16.3 A.I. Analysis, Inc Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
- 7.16.4 A.I. Analysis, Inc Brain Disease Device and Software Product Portfolio
- 7.16.5 A.I. Analysis, Inc Recent Developments
8 North America
- 8.1 North America Brain Disease Device and Software Revenue (2021-2032)
- 8.2 North America Brain Disease Device and Software Revenue by Type (2021-2032)
- 8.2.1 North America Brain Disease Device and Software Revenue by Type (2021-2026)
- 8.2.2 North America Brain Disease Device and Software Revenue by Type (2027-2032)
- 8.3 North America Brain Disease Device and Software Revenue Share by Type (2021-2032)
- 8.4 North America Brain Disease Device and Software Revenue by Application (2021-2032)
- 8.4.1 North America Brain Disease Device and Software Revenue by Application (2021-2026)
- 8.4.2 North America Brain Disease Device and Software Revenue by Application (2027-2032)
- 8.5 North America Brain Disease Device and Software Revenue Share by Application (2021-2032)
- 8.6 North America Brain Disease Device and Software Revenue by Country
- 8.6.1 North America Brain Disease Device and Software Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Brain Disease Device and Software Revenue by Country (2021-2026)
- 8.6.3 North America Brain Disease Device and Software Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Brain Disease Device and Software Revenue (2021-2032)
- 9.2 Europe Brain Disease Device and Software Revenue by Type (2021-2032)
- 9.2.1 Europe Brain Disease Device and Software Revenue by Type (2021-2026)
- 9.2.2 Europe Brain Disease Device and Software Revenue by Type (2027-2032)
- 9.3 Europe Brain Disease Device and Software Revenue Share by Type (2021-2032)
- 9.4 Europe Brain Disease Device and Software Revenue by Application (2021-2032)
- 9.4.1 Europe Brain Disease Device and Software Revenue by Application (2021-2026)
- 9.4.2 Europe Brain Disease Device and Software Revenue by Application (2027-2032)
- 9.5 Europe Brain Disease Device and Software Revenue Share by Application (2021-2032)
- 9.6 Europe Brain Disease Device and Software Revenue by Country
- 9.6.1 Europe Brain Disease Device and Software Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Brain Disease Device and Software Revenue by Country (2021-2026)
- 9.6.3 Europe Brain Disease Device and Software Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Brain Disease Device and Software Revenue (2021-2032)
- 10.2 China Brain Disease Device and Software Revenue by Type (2021-2032)
- 10.2.1 China Brain Disease Device and Software Revenue by Type (2021-2026)
- 10.2.2 China Brain Disease Device and Software Revenue by Type (2027-2032)
- 10.3 China Brain Disease Device and Software Revenue Share by Type (2021-2032)
- 10.4 China Brain Disease Device and Software Revenue by Application (2021-2032)
- 10.4.1 China Brain Disease Device and Software Revenue by Application (2021-2026)
- 10.4.2 China Brain Disease Device and Software Revenue by Application (2027-2032)
- 10.5 China Brain Disease Device and Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Brain Disease Device and Software Revenue (2021-2032)
- 11.2 Asia Brain Disease Device and Software Revenue by Type (2021-2032)
- 11.2.1 Asia Brain Disease Device and Software Revenue by Type (2021-2026)
- 11.2.2 Asia Brain Disease Device and Software Revenue by Type (2027-2032)
- 11.3 Asia Brain Disease Device and Software Revenue Share by Type (2021-2032)
- 11.4 Asia Brain Disease Device and Software Revenue by Application (2021-2032)
- 11.4.1 Asia Brain Disease Device and Software Revenue by Application (2021-2026)
- 11.4.2 Asia Brain Disease Device and Software Revenue by Application (2027-2032)
- 11.5 Asia Brain Disease Device and Software Revenue Share by Application (2021-2032)
- 11.6 Asia Brain Disease Device and Software Revenue by Country
- 11.6.1 Asia Brain Disease Device and Software Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Brain Disease Device and Software Revenue by Country (2021-2026)
- 11.6.3 Asia Brain Disease Device and Software Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Brain Disease Device and Software Revenue (2021-2032)
- 12.2 SAMEA Brain Disease Device and Software Revenue by Type (2021-2032)
- 12.2.1 SAMEA Brain Disease Device and Software Revenue by Type (2021-2026)
- 12.2.2 SAMEA Brain Disease Device and Software Revenue by Type (2027-2032)
- 12.3 SAMEA Brain Disease Device and Software Revenue Share by Type (2021-2032)
- 12.4 SAMEA Brain Disease Device and Software Revenue by Application (2021-2032)
- 12.4.1 SAMEA Brain Disease Device and Software Revenue by Application (2021-2026)
- 12.4.2 SAMEA Brain Disease Device and Software Revenue by Application (2027-2032)
- 12.5 SAMEA Brain Disease Device and Software Revenue Share by Application (2021-2032)
- 12.6 SAMEA Brain Disease Device and Software Revenue by Country
- 12.6.1 SAMEA Brain Disease Device and Software Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Brain Disease Device and Software Revenue by Country (2021-2026)
- 12.6.3 SAMEA Brain Disease Device and Software Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst